Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: A prospective cohort study

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Davis, J L ^a,c   Huang, Laurence ^a,c   Worodria, William ^c   Masur, Henry ^b   Cattamanchi, Adithya ^a,c   Huber, Charles ^b   Miller, Cecily ^a   Conville, Patricia S ^b   Murray, Patrick ^b   Kovacs, Joseph A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; COTRIMOXAZOLE; PROTEIN SECA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL GENE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FEMALE; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SECA1 GENE; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM SMEAR; TUBERCULOSIS; UGANDA;

ADULT; COHORT STUDIES; COMORBIDITY; HIV INFECTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

BACILLI (CLASS); MYCOBACTERIUM TUBERCULOSIS;

EID: 79961005832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016321     Document Type: Article

References (30)

1. World Health Organization (2010) Global TB Control Report 2010. Geneva: World Health Organization.
2. Cambanis A, Ramsay A, Wirkom V, Tata E, Cuevas LE (2007) Investing time in microscopy: an opportunity to optimise smear-based case detection of tuberculosis. Int J Tuberc Lung Dis 11: 40-45.
3. Sarmiento OL, Weigle KA, Alexander J, Weber DJ, Miller WC (2003) Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol 41: 3233-3240.
4. Flores LL, Pai M, Colford JM, Jr., Riley LW (2005) In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol 5: 55.
5. Greco S, Girardi E, Navarra A, Saltini C (2006) Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 61: 783-790.
6. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N Engl J Med 363: 1005-1015.
7. Davis JL, Huang L, Kovacs JA, Masur H, Murray P, et al. (2009) Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin Infect Dis 48: 725-732.
8. Cattamanchi A, Davis JL, Worodria W, Yoo S, Matovu J, et al. (2008) Poor performance of universal sample processing method for diagnosis of pulmonary tuberculosis by smear microscopy and culture in Uganda. J Clin Microbiol 46: 3325-3329.
9. Cattamanchi A, Davis JL, Worodria W, den Boon S, Yoo S, et al. (2009) Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis 13: 1130-1136.
10. Cattamanchi A, Dowdy DW, Davis JL, Worodria W, Yoo S, et al. (2009) Sensitivity of direct versus concentrated sputum smear microscopy in HIVinfected patients suspected of having pulmonary tuberculosis. BMC Infect Dis 9: 53-56.
11. Davis JL, Worodria W, Kisembo H, Metcalfe JZ, Cattamanchi A, et al. (2010) Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study. PLoS One 5: e9859.
12. Cattamanchi A, Ssewenyana I, Davis JL, Huang L, Worodria W, et al. (2010) Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis 10: 75.
13. Worodria W, Davis JL, Cattamanchi A, Andama A, den Boon S, et al. (2010) Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIVinfected patients. Eur Respir J 36: 446-448.
14. Yoo S, Worodria W, Davis JL, Cattamanchi A, den Boon S, et al. (2010) The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda. J Acquir Immune Defic Syndr 54: 269-274.
15. Kyeyune R, den Boon S, Cattamanchi A, Davis JL, Worodria W, et al. (2010) Causes of Early Mortality in HIV-Infected TB Suspects in an East African Referral Hospital. J Acquir Immune Defic Syndr 55: 446-450.
16. Khan MS, Dar O, Sismanidis C, Shah K, Godfrey-Faussett P (2007) Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial. Lancet 369: 1955-1960.
17. (2000) Technical Guide to Sputum Examination for Tuberculosis by Direct Microscopy in Low Income Countries. 5th ed. Paris: International Union Against Tuberculosis and Lung Disease.
18. Kent PT, Kubica GP (1985) Public Health Mycobacteriology. A Guide for the Level III Laboratory. Atlanta: Centers for Disease Control.
19. Zelazny AM, Calhoun LB, Li L, Shea YR, Fischer SH (2005) Identification of Mycobacterium species by secA1 sequences. J Clin Microbiol 43: 1051-1058.
20. Lord SJ, Irwig L, Bossuyt PM (2009) Using the principles of randomized controlled trial design to guide test evaluation. Med Decis Making 29: E1-E12.
21. (2009) Pathways to better diagnostics for tuberculosis. Geneva: World Health Organization, and the Stop TB Partnership New Diagnostics Working Group.
22. Dowdy DW, Chaisson RE, Moulton LH, Dorman SE (2006) The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS 20: 751-762.
23. Keeler E, Perkins MD, Small P, Hanson C, Reed S, et al. (2006) Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444(Suppl 1): 49-57.
24. van Cleeff M, Kivihya-Ndugga L, Githui W, Ng'ang'a L, Kibuga D, et al. (2005) Cost-effectiveness of polymerase chain reaction versus Ziehl-Neelsen smear microscopy for diagnosis of tuberculosis in Kenya. Int J Tuberc Lung Dis 9: 877-883.
25. Dowdy DW, O'Brien MA, Bishai D (2008) Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 12: 1021-1029.
26. Kambashi B, Mbulo G, McNerney R, Tembwe R, Kambashi A, et al. (2001) Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis 5: 364-369.
27. Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, et al. (2008) Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336: 1106-1110.
28. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, et al. (1999) Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282: 1061-1066.
29. Pai M, O'Brien R (2006) Tuberculosis diagnostics trials: do they lack methodological rigor? Expert Rev Mol Diagn 6: 509-514.
30. Kivihya-Ndugga L, van Cleeff M, Juma E, Kimwomi J, Githui W, et al. (2004) Comparison of PCR with the routine procedure for diagnosis of tuberculosis in a population with high prevalences of tuberculosis and human immunodeficiency virus. J Clin Microbiol 42: 1012-1015.